Incyte Biosciences Denmark ApS: Financial statements 2023
CVR: 35818790
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
Incyte Biosciences Denmark ApS (CVR 35818790) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 6,283,403 and a net result of DKK 374,584 compared with DKK 277,949 the year before. That is an increase of 13.1% compared with the year before. Equity in the 2023 report amounted to DKK 1,598,472. The solvency ratio was 34.7%. The company had 4 employees in the financial year.
- Gross Profit
- DKK 6,283,403
- Profit/Loss
- DKK 374,584
- Equity
- DKK 1,598,472
- Total Assets
- DKK 4,603,464
- Employees
- 4
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | 6.3M | 375K | 1.6M | 4 |
| 2022 | - | 5.6M | 278K | 1.2M | 4 |
| 2021 | - | 5.3M | 269K | 946K | 4 |
| 2020 | - | 5.4M | 150K | 677K | 3 |
| 2019 | - | 4.8M | 286K | 527K | 3 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
Incyte Biosciences Denmark ApS has published its annual report for 2022. Gross profit came to DKK 5,556,640, and the net result was DKK 277,949.
About Incyte Biosciences Denmark ApS
Incyte Biosciences Denmark ApS is a Danish company of the type Anpartsselskab based in Frederiksberg C, founded in 2014. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named ARIAD PHARMACEUTICALS (DENMARK) ApS. The management consists of Ebba Cecilia Bröms. The board consists of Lee Jason Heeson (chair) and Ebba Cecilia Bröms. The company is owned by Incyte Biosciences International Sàrl. The company has 4 employees (2026). In 2025, the company reported a gross profit of DKK 6,696,586 and a net result of DKK 361,151 compared with DKK 368,873 the year before. Equity in the 2025 report amounted to DKK 2,328,496.
